(Q39268041)

10 September 2017

Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway (English)

1 reference

10 September 2017

1 reference

Yeong-In Yang

1

1 reference

10 September 2017

Kyung-Tae Lee

2

1 reference

10 September 2017

Hee-Juhn Park

3

1 reference

10 September 2017

Tae Jin Kim

4

1 reference

10 September 2017

Youn Seok Choi

5

1 reference

10 September 2017

Ie-Ming Shih

6

1 reference

10 September 2017

Jung-Hye Choi

7

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

33

1 reference

10 September 2017

12

1 reference

10 September 2017

2488-2498

1 reference

Global cancer statistics, 2002

10 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Up date in the management of advanced ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Ovarian cancer: strategies for overcoming resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Role of apoptotic response in cellular resistance to cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Options for modulation of drug resistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Flavonoids, a class of natural products of high pharmacological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Dietary flavonoids as cancer-preventive and therapeutic biofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

The proportional odds model for multivariate interval-censored failure time data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Estrogenic effect of main components kakkalide and tectoridin of Puerariae Flos and their metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Phytoestrogens derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Tectorigenin, an isoflavone of Pueraria thunbergiana Benth., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Role of triptolide as an adjunct chemotherapy for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Cytotoxic effects of compounds from Iris tectorum on human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Phytoestrogen biological actions on Mammalian reproductive system and cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Endocrine Factors in Common Epithelial Ovarian Cancer*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

The role of oxidative stress in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Inhibition of nuclear factor-kappaB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Structure and mechanism in NF-kappa B/I kappa B signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Mutant p53 cooperates with ETS2 to promote etoposide resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS302

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS302

1 reference

10 September 2017

1 reference